| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/04/2008 | US20080213237 Antigen Specific Lymphocytes, Compositions Thereof, and Methods for Isolation and Preparation Thereof |
| 09/04/2008 | US20080213233 Using vector transfer to preferential gene sequence into cells; treating nervous system, cell proliferative, muscle, kidney and pancreatic disorders |
| 09/04/2008 | US20080213227 Using animal progenitor cell culture to propagate organ tissues; tissue engineering; tissue repair; regenerative medicine; treating cell proliferative, arthritic, autoimmune, skin and inflammatory disorders |
| 09/04/2008 | US20080213225 Sulfur-oxidizing plant growth promoting rhizobacteria for enhanced canola performance |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | US20080213218 Method for treating hepatitis c virus infection in treatment failure patients |
| 09/04/2008 | US20080213213 Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione |
| 09/04/2008 | US20080213203 Antiperspirant compositions comprising cyclodextrin complexing material |
| 09/04/2008 | US20080213178 Using a radiolabeled fatty acid analog such as endo-[18F] fluoro- or [123I]iodo-3,4-cyclopropylheptadecanoic acid localized in tissue of interest, imaging, determining blood flow rate |
| 09/04/2008 | US20080213176 Labelled peptide; an amino acid sequence of at least 7 amino acids, comprising a mid-part having a lysine residue, and terminal parts comprising consecutive glycine residues |
| 09/04/2008 | US20080213172 Radioimaging moieties coupled to peptidease-binding moieties for imaging tissues and organs that express peptidases |
| 09/04/2008 | US20080213170 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 09/04/2008 | CA2679266A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | CA2679263A1 Sulfonamide compound |
| 09/04/2008 | CA2679126A1 Macrocyclic compound |
| 09/04/2008 | CA2678735A1 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964852A1 Anti-ilt7 antibody |
| 09/03/2008 | EP1964843A1 Process for production of water-soluble azole prodrug |
| 09/03/2008 | EP1964841A1 Imidazo[1,2-a]azine and their use as pharmaceuticals |
| 09/03/2008 | EP1964839A2 Quinazoline derivatives as kinase inhibitors |
| 09/03/2008 | EP1964837A1 Anti-tumor agent for multiple myeloma |
| 09/03/2008 | EP1964574A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
| 09/03/2008 | EP1962861A2 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 09/03/2008 | EP1962859A1 Vitamin d derivatives for the treatment of type i diabetes |
| 09/03/2008 | EP1962838A2 Farnesoid x receptor agonists |
| 09/03/2008 | EP1487401A4 A substantially visibly transparent topical physical sunscreen formulation |
| 09/03/2008 | EP1480647B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 09/03/2008 | EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses |
| 09/03/2008 | EP1431347B1 Composition containing fine particles as carriers for biologically active substance and method for preparing these |
| 09/03/2008 | EP1426443B1 Human bmcc1 gene |
| 09/03/2008 | EP1415667B1 Pancreatic juice secretion regulators comprising lpa receptor controller |
| 09/03/2008 | EP1389094B1 Delivery of sedative-hypnotics trough an inhalation route |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1339398B1 Treatment of motor fluctuations with 5-hydroxytryptamine 1a receptor activity enhancing compounds |
| 09/03/2008 | EP1328289B1 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 09/03/2008 | EP1311708B1 Method for identifying substances useful for treating inflammation using the response element to the ikappabaplha ror receptor |
| 09/03/2008 | EP1311480B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/03/2008 | EP1261349B1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 09/03/2008 | EP1257541B1 Polypharmacophoric agents |
| 09/03/2008 | EP1121129B1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS |
| 09/03/2008 | EP1042293B9 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 09/03/2008 | EP0852463B1 Myogenic differentiation of human mesenchymal stem cells |
| 09/03/2008 | EP0804576B1 A novel haemopoietin receptor |
| 09/03/2008 | EP0789575B1 Peripheral nervous system specific sodium channels, dna encoding therefor, drug screening, and methods of making and using thereof |
| 09/03/2008 | EP0710116B1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 09/03/2008 | CN101258240A Protein preparation containing S1-5 |
| 09/03/2008 | CN101257915A Method of inhibiting angiogenesis by using ephrin B2 |
| 09/03/2008 | CN101257904A Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
| 09/03/2008 | CN101257896A Growth promoting agent and life prolonging agent |
| 09/03/2008 | CN101254287A Medicament containing aminoglucose and uses thereof |
| 09/03/2008 | CN101254191A Use of quinazoline glyoxaline compounds |
| 09/03/2008 | CN100415772C Anti-ErbB2 antibodies |
| 09/03/2008 | CN100415770C 2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}- alkylboronic acid derivatives |
| 09/03/2008 | CN100415753C 4-dimethylamino crotonic acid, its derivatives and their preparing method |
| 09/03/2008 | CN100415747C Phosphodiesterase 4 inhibitors |
| 09/03/2008 | CN100415744C 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 09/03/2008 | CN100415743C Derivatives of pyrimido [6.1-a] isoquinolin-4-one |
| 09/03/2008 | CN100415742C Novel hydrochloride compound and use thereof |
| 09/03/2008 | CN100415724C Pyrimidine derivatives |
| 09/03/2008 | CN100415723C Benzimidazole derivative |
| 09/03/2008 | CN100415719C 2,5-disubstituted 3-mercaptopentanoic acid |
| 09/03/2008 | CN100415716C 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative |
| 09/03/2008 | CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection |
| 09/03/2008 | CN100415222C Methods of using and compositions comprising dopamine reuptake inhibitors |
| 09/03/2008 | CN100415219C Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients |
| 09/03/2008 | CN100415206C Whitening agent, skin preparation for external use and cosmetic |
| 09/02/2008 | US7420069 Crystalline composition containing escitalopram |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420053 2-imino-1,3-thiazine derivatives |
| 09/02/2008 | US7420050 TGF-β-specific covalently closed antisense molecule |
| 09/02/2008 | US7420042 Soluble neuropilin/growth factor receptor fusion proteins |
| 09/02/2008 | US7420029 A tissue-specific transporter function inhibitor has both a ligand structure recognized by a tissue-specific transporter and a polymeric molecular structure incapable of passing through a membrane tissue |
| 09/02/2008 | US7420003 Compounds and a novel process for their preparation |
| 09/02/2008 | US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues |
| 09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419970 Cosmetic compositions comprising N-acylamino amides |
| 09/02/2008 | US7419968 Screening for anticancer drugs for treating cells that endogenously overexpress intracellular thymidylate synthase by contacting the cell with the candidate and (E)-5-(2-bromovinyl)-2'-deoxy-5'-uridyl phenyl L-alaninylphosphoramidate and assaying for cell death |
| 09/02/2008 | US7419955 Especially from intimal thickening, by administering a C-terminal globular domain of adiponectin to down-regulate expression of scavenger receptor A |
| 09/02/2008 | US7419950 Methods of inhibiting ectopic calcification |
| 09/02/2008 | US7419948 Recombinant human Factor IX produced by a transgenic pig having an exogenous DNA stably integrated into its genome that secretes the biologically active Factor into its milk; the factor may be gamma -carboxylated |
| 09/02/2008 | US7419814 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/02/2008 | US7419807 High molecular weight; isolated nucleic acid; use in detecting antibodies in test sample; diagnostic kit |
| 09/02/2008 | US7419804 CASH (Caspase Homologue) with death effector domain, modulators of the function of FAS |
| 09/02/2008 | US7419793 Flea octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 09/02/2008 | US7419790 Sodium-independent transporter carrying acidic amino acid and its gene |
| 09/02/2008 | US7419686 For preventing oral abuse of an oral opioid formulation; provides a negative, "aversive" experience when a large amount of the opioid, e.g., about 2-3 times the usually prescribed dose, is taken by or administered to a physically dependent subject |
| 09/02/2008 | US7419667 Drug for cancer therapy |
| 09/02/2008 | CA2440468C Pregabalin lactose conjugates |
| 09/02/2008 | CA2395037C The use of scopolamine salts |
| 09/02/2008 | CA2389333C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 09/02/2008 | CA2388140C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 09/02/2008 | CA2387999C Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures |
| 09/02/2008 | CA2386813C Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 09/02/2008 | CA2350609C N-substituted 2-cyanopyrrolidines |
| 09/02/2008 | CA2325818C Topical immunostimulation to induce langerhans cell migration |